Delivery Order SPE2DB22D2206-SPE2DB26FDT28
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Albuterol 25% solution in 50-milliliter vials. This firm fixed-price delivery order, valued at $1,188.00, represents a competitive award with no set-aside designation and is scheduled for completion by August 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,378.96 to AmerisourceBergen Drug Corp for the supply of Albuterol 2.5 mg/0.5 mL solution in unit dose format (30 units). This firm fixed price, competitively awarded contract was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. Performance will take place at AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,992.00 to AmerisourceBergen Drug Corp for the supply of Albuterol Sulfate 2.5 mg/3 mL solution in unit dose 3 mL vials. This firm fixed price, competitively awarded delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $1,964.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a small-value pharmaceutical supply transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Albuterol HFA 90 MCG inhalers (8.5GM) under a firm fixed price contract valued at $1,442.88. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,773.92 to AmerisourceBergen Drug Corp for Albuterol HFA 90 micrograms inhalers (8.5 grams) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Albuterol HFA 90 mcg inhalers in 8.5-gram units, with a ceiling value of $1,026.95 under a firm fixed price contract structure. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,001.00 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams). The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDT28Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Albuterol 25% Vial 100ML pharmaceutical product, with a ceiling value of $4,336.40 and an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with no set-aside designation. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. As a critical vendor in the federal medical supply chain, AmerisourceBergen has demonstrated its capability to fulfill federal procurement requirements across multiple therapeutic domains through consistent competitively awarded contracts with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 10/22/25 |